Historique
Auteur S. ASSI
Documents disponibles écrits par cet auteur (6)
Ajouter le résultat à votre sélection Affiner la recherche
C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO | 2012
Dans Human Psychopharmacology: Clinical and Experimental (Vol.27, n°2, March 2012) Article : PériodiqueOBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]
From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine
O. CORAZZA ; S. ASSI ; F. SCHIFANO | 2013
Dans CNS Neuroscience and Therapeutics (Vol.19, n°6, June 2013) Article : PériodiqueThis article reviews the recreational use of ketamine ("Special K"; KET) and explores the recent diffusion of its new derivative methoxetamine ("Special M"; MXE). The literature search on the nonclinical/recreational use of KET and MXE was carri[...]
O. CORAZZA ; S. ASSI ; S. MALEKIANRAGHEB ; M. N. BENI ; I. BIGDELI ; Z. ASLANPOUR ; F. SCHIFANO | 2014
Dans International Journal of Drug Policy (Vol.25, n°4, July 2014) Article : PériodiqueBackground: Numbers of novel psychoactive substances (NPS) have been rapidly increasing over the past few years, with unprecedented challenges on traditional drug control systems. The web has been involved in the promotion and knowledge dissemin[...]
O. CORAZZA ; F. SCHIFANO ; P. SIMONATO ; S. FERGUS ; S. ASSI ; J. L. STAIR ; J. CORKERY ; G. TRINCAS ; P. DELUCA ; Z. DAVEY ; U. BLASZKO ; Z. DEMETROVICS ; J. MOSKALEWICZ ; A. ENEA ; G. DI MELCHIORRE ; B. MERVO ; L. DI FURIA ; M. FARRE ; L. H. FLESLAND ; M. PASINETTI ; C. PEZZOLESI ; A. PISARSKA ; H. SHAPIRO ; H. SIEMANN ; A. SKUTLE ; E. SFERRAZZA ; M. TORRENS ; P. VAN DER KREEFT ; D. ZUMMO ; N. SCHERBAUM | 2012
Dans Human Psychopharmacology: Clinical and Experimental (Vol.27, n°2, March 2012) Article : PériodiqueOn the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to [...]
S. ASSI ; D. MARSHALL ; F. S. BERSANI ; O. CORAZZA | 2020
Dans Journal of Psychoactive Drugs (Vol.52, n°3, July-August 2020) Article : PériodiqueSynthetic cannabinoids (SCs) are a class of synthetic chemicals with cannabis-like properties, and little is known about their pharmacological and toxicological effects. The objective of this study was to explore the effects of SCs and the under[...]
